Canopy Growth Corp Restructuring Costs and Asset Impairment Charges
Canopy Growth Corp (CGC) reported Restructuring Costs and Asset Impairment Charges of CAD 67.08 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:RestructuringCostsAndAssetImpairmentCharges · last filed 2026-06-15
- Canopy Growth Corp restructuring costs and asset impairment charges for the quarter ending 2023-06-30 was 2.16M CAD, a 99.87% decline year-over-year.
- Canopy Growth Corp restructuring costs and asset impairment charges for the quarter ending 2023-03-31 was 405.13M CAD, a 68.01% increase year-over-year.
- Canopy Growth Corp restructuring costs and asset impairment charges for the quarter ending 2022-12-31 was 22.26M CAD, a 38.91% decline year-over-year.
- Canopy Growth Corp restructuring costs and asset impairment charges for the quarter ending 2022-09-30 was 101.37M CAD, a 3938.61% increase year-over-year.
- Canopy Growth Corp restructuring costs and asset impairment charges for fiscal 2026 was 67.08M CAD, a 114.77% increase from fiscal 2025.
- Canopy Growth Corp restructuring costs and asset impairment charges for fiscal 2025 was 31.23M CAD, a 52.67% decline from fiscal 2024.
- Canopy Growth Corp restructuring costs and asset impairment charges for fiscal 2024 was 65.99M CAD, a 97.08% decline from fiscal 2023.
- Canopy Growth Corp restructuring costs and asset impairment charges for fiscal 2023 was 2.26B CAD, a 511.02% increase from fiscal 2022.
| Period end | Restructuring Costs and Asset Impairment Charges 3 month | Restructuring Costs and Asset Impairment Charges 3 month as first filed | Restructuring Costs and Asset Impairment Charges 6 month | Restructuring Costs and Asset Impairment Charges 6 month as first filed | Restructuring Costs and Asset Impairment Charges 9 month | Restructuring Costs and Asset Impairment Charges 9 month as first filed | Restructuring Costs and Asset Impairment Charges 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | 67.08M CAD 10-K · filed 2026-06-15 | ||||||
| 2025-03-31 | 31.23M CAD 10-K · filed 2026-06-15 | ||||||
| 2024-03-31 | 65.99M CAD 10-K · filed 2026-06-15 | ||||||
| 2023-06-30 | 2.16M CAD 10-Q · filed 2023-08-09 | 407.29M CAD derived: sum of 2 quarters · filed 2023-08-09 | 429.55M CAD derived: sum of 3 quarters · filed 2023-08-09 | 530.92M CAD derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2023-03-31 | 405.13M CAD derived: 10-K 12 month − 10-K 9 month · filed 2023-06-22 | 427.39M CAD derived: sum of 2 quarters · filed 2023-06-22 | 528.76M CAD derived: sum of 3 quarters · filed 2023-06-22 | 2.26B CAD 10-K · filed 2023-06-22 | |||
| 2022-12-31 | 22.26M CAD 10-Q · filed 2023-02-09 | 123.63M CAD derived: sum of 2 quarters · filed 2023-06-22 | 1.85B CAD 10-K · filed 2023-06-22 | 1.79B CAD 10-Q · filed 2023-02-09 | 2.09B CAD derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-09-30 | 101.37M CAD 10-K · filed 2023-06-22 | 43.97M CAD 10-Q · filed 2022-11-09 | 1.83B CAD 10-K · filed 2023-06-22 | 1.77B CAD 10-Q · filed 2022-11-09 | 2.07B CAD derived: sum of 3 quarters · filed 2023-08-09 | 2.11B CAD derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | 1.73B CAD 10-Q · filed 2023-08-09 | 1.97B CAD derived: sum of 2 quarters · filed 2023-08-09 | 2.01B CAD derived: sum of 3 quarters · filed 2023-08-09 | 2.01B CAD derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | 241.14M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 277.58M CAD derived: sum of 2 quarters · filed 2023-06-22 | 280.09M CAD derived: sum of 3 quarters · filed 2023-06-22 | 369.34M CAD 10-K · filed 2023-06-22 | |||
| 2021-12-31 | 36.44M CAD 10-Q · filed 2023-02-09 | 38.95M CAD derived: sum of 2 quarters · filed 2023-02-09 | 128.20M CAD 10-Q · filed 2023-02-09 | 203.02M CAD derived: sum of 4 quarters · filed 2023-06-22 | |||
| 2021-09-30 | 2.51M CAD 10-Q · filed 2022-11-09 | 91.76M CAD 10-Q · filed 2022-11-09 | 166.58M CAD derived: sum of 3 quarters · filed 2023-06-22 | 567.00M CAD derived: sum of 4 quarters · filed 2023-06-22 | |||
| 2021-06-30 | 89.25M CAD 10-Q · filed 2022-08-09 | 164.07M CAD derived: sum of 2 quarters · filed 2023-06-22 | 564.49M CAD derived: sum of 3 quarters · filed 2023-06-22 | 610.85M CAD derived: sum of 4 quarters · filed 2023-06-22 | |||
| 2021-03-31 | 74.82M CAD derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | 475.24M CAD derived: sum of 2 quarters · filed 2023-06-22 | 521.60M CAD derived: sum of 3 quarters · filed 2023-06-22 | 534.40M CAD 10-K · filed 2023-06-22 | |||
| 2020-12-31 | 400.42M CAD 10-Q · filed 2022-02-09 | 446.79M CAD derived: sum of 2 quarters · filed 2022-02-09 | 459.58M CAD 10-Q · filed 2022-02-09 | ||||
| 2020-09-30 | 46.36M CAD 10-Q · filed 2021-11-08 | 59.16M CAD 10-Q · filed 2021-11-08 | |||||
| 2020-06-30 | 12.79M CAD 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | 623.27M CAD 10-K · filed 2022-05-31 | ||||||
| 2019-03-31 | 0.00 CAD 10-K · filed 2021-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |